LiPlaCis

Phase 2

Phase 2

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in Phase 1: Advanced or Refractory Solid Tumours

Drug Information

Target Indication

Phase 1: Advanced or Refractory Solid Tumours

Clinical Trial

Last updated: 1/2/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

ALLR

Allarity Therapeutics, Inc.

Related Pipeline

Advanced Ovarian Cancer

Metastatic Breast Cancer

Metastatic Castration-Resistant Prostate Cancer Patients